Highbridge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Highbridge Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,778	Closed	-$1.82M	–	842
2018 Q2	$1.82M	Buy	+8,778	New	+$1.86M	0.04%	394
2017 Q4	–	Sell	-11,216	Closed	-$2.12M	–	1965
2017 Q3	$2.12M	Buy	+11,216	New	+$2.03M	0.03%	426
2017 Q2	–	Sell	-11,688	Closed	-$1.79M	–	1598
2017 Q1	$1.79M	Buy	11,688 +3,642	+45%	+$557K	0.03%	471
2016 Q4	$1.14M	Buy	+8,046	New	+$1.19M	0.02%	516
2015 Q3	–	Sell	-96,462	Closed	-$12.5M	–	1811
2015 Q2	$12.5M	Buy	96,462 +94,742	+5,508%	+$12.4M	0.16%	153
2015 Q1	$231K	Buy	+1,720	New	+$222K	﹤0.01%	1220
2014 Q4	–	Sell	-4,939	Closed	-$601K	–	1432
2014 Q3	$601K	Buy	+4,939	New	+$601K	0.01%	810
2014 Q2	–	Sell	-46,732	Closed	-$5.62M	–	1293
2014 Q1	$5.62M	Buy	+46,732	New	+$5.56M	0.07%	253

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Highbridge Capital Management's TMO Position: Q3 2018 in Review

Highbridge Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2018, closing a stake of 8,778 shares — an estimated $1.82M sold.

Highbridge Capital Management first reported a position in TMO in Q1 2014 and held it in 8 quarters. The position peaked at $12.5M in Q2 2015. 1,350 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

Highbridge Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 8,778 Thermo Fisher Scientific shares in Q3 2018, an estimated $1.82M.
Highbridge Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 8 quarters.
Highbridge Capital Management's Thermo Fisher Scientific position peaked at $12.5M in Q2 2015.
1,350 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.